Werewolf Therapeutics (HOWL) Price to Sales (2022 - 2026)

Werewolf Therapeutics (HOWL) has reported Price to Sales for 4 consecutive years, with 0.83 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales changed N/A year-over-year to 0.83 in Q2 2026; TTM through Jun 2026 was 0.83, a 99.97% decrease from a year earlier, with the FY2024 full-year figure at 34.92, up 361.31% from the prior year.
• Price to Sales was 0.83 for Q2 2026 at Werewolf Therapeutics, down from 4422.95 in the prior quarter.
• Over five years, Price to Sales peaked at 4422.95 in Q4 2024 and troughed at 0.83 in Q2 2026.
• A 4-year average of 464.28 and a median of 27.78 in 2022 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales sank 53.42% in 2023 and soared 4297.95% in 2024, its largest moves.
• Over 4 years, Price to Sales stood at 8.85 in 2022, then surged by 1036.63% to 100.57 in 2023, then soared by 4297.95% to 4422.95 in 2024, then plunged by 99.98% to 0.83 in 2026.
• The last three Price to Sales figures came in at 0.83 (Q2 2026), 4422.95 (Q4 2024), and 93.29 (Q2 2024), per Business Quant data.